Literature DB >> 17103212

Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.

Zeying Du1, David W Gjertson, Elaine F Reed, Raja Rajalingam.   

Abstract

Interactions between inhibitory killer cell immunoglobulin-like receptors (iKIR) and human leukocyte antigen (HLA) class I molecules regulate natural killer (NK) cell responses to eliminate infected and transformed cells while maintaining tolerance to healthy cells. Unlinked polymorphic gene families encode KIR receptors and HLA class I ligands and their independent segregation results in a variable number and type of iKIR + HLA pairs inherited in individuals. The diversity in the co-inheritance of iKIR + HLA pairs and activating KIR (aKIR) genes in 759 unrelated individuals from four ethnic populations was analyzed. Every individual studied inherited a minimum of one iKIR + HLA pair; suggesting that major histocompatibility complex class I-dependent inhibitory KIR signaling is essential for human NK cell function. In contrast, 13.4% of the study group lacked all aKIR genes. Twenty percent of the study group carried only one of the four iKIR + HLA pairs. Interestingly, 3% of the study group carrying only KIR2DL3 + HLA-C1 as an iKIR + HLA pair lacked aKIR genes. These data suggest that a single iKIR can constitute the minimal KIR repertoire for human NK cells. Genotypes carrying an equal number of iKIR + HLA pairs and aKIR genes represented 20% of the study group. The remaining individuals had either a dominant inhibitory KIR genotype (iKIR + HLA > aKIR) or a dominant activating KIR genotype (iKIR + HLA < aKIR). Genotypes encoding these imbalanced inhibitory and activating interactions may contribute to susceptibility or resistance to human diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17103212     DOI: 10.1007/s00251-006-0168-4

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  119 in total

1.  Genomic diversity of natural killer cell receptor genes in three populations.

Authors:  M Toneva; V Lepage; G Lafay; N Dulphy; M Busson; S Lester; A Vu-Trien; A Michaylova; E Naumova; J McCluskey; D Charron
Journal:  Tissue Antigens       Date:  2001-04

Review 2.  Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors.

Authors:  M Colonna
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

Review 3.  Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).

Authors:  E O Long; D F Barber; D N Burshtyn; M Faure; M Peterson; S Rajagopalan; V Renard; M Sandusky; C C Stebbins; N Wagtmann; C Watzl
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

4.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

5.  Inhibitory and activatory KIR gene frequencies in the Polish population.

Authors:  W Luszczek; E Majorczyk; I Nowak; A Pawlik; M Jasek; A Wiśniewski; P Kuśnierczyk
Journal:  Int J Immunogenet       Date:  2006-06       Impact factor: 1.466

6.  Distribution of killer-cell immunoglobulin-like receptor (KIR) in Comoros and Southeast France.

Authors:  C Frassati; M Touinssi; C Picard; M Segura; V Galicher; K Papa; K Gagne; E Vivier; A Degioanni; G Böetsch; P Mercier; F Vély; P de Micco; D Reviron; J Chiaroni
Journal:  Tissue Antigens       Date:  2006-05

7.  Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.

Authors:  T Bellón; A B Heredia; M Llano; A Minguela; A Rodriguez; M López-Botet; P Aparicio
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

8.  Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles.

Authors:  H Kelly; V J McCann; P H Kay; R L Dawkins
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  Stress signals activate natural killer cells.

Authors:  Eric O Long; Sumati Rajagopalan
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  36 in total

1.  Evaluation of KIR genes in recurrent miscarriage.

Authors:  Ozlem Goruroglu Ozturk; Gulhan Sahın; Esin Damla Zıyanoglu Karacor; Umran Kucukgoz
Journal:  J Assist Reprod Genet       Date:  2012-06-06       Impact factor: 3.412

2.  Natural killer cell immunoglobulin-like receptors (KIR) genotypes in two arab populations: will KIR become a genetic landmark between nations?

Authors:  Roni Rayes; Ali Bazarbachi; Georges Khazen; Amira Sabbagh; Ghazi Zaatari; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2007-03-26       Impact factor: 2.316

3.  Presence of more activating KIR genes is associated with Hashimoto's thyroiditis.

Authors:  Elham Ashouri; Mohammad Hossein Dabbaghmanesh; Gholamhossein Ranjbar Omrani
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

4.  KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China.

Authors:  Song Hu; Fahu Yuan; Lingyan Feng; Fang Zheng; Feili Gong; Hanju Huang; Binlian Sun
Journal:  Virol Sin       Date:  2018-07-23       Impact factor: 4.327

5.  Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma.

Authors:  Anupam Dutta; Nabajyoti Saikia; Jyotirmoy Phookan; Munindra Narayan Baruah; Shashi Baruah
Journal:  Immunogenetics       Date:  2014-05-13       Impact factor: 2.846

6.  Human NK cells licensed by killer Ig receptor genes have an altered cytokine program that modifies CD4+ T cell function.

Authors:  Lin Lin; Chao Ma; Bo Wei; Najib Aziz; Raja Rajalingam; Susy Yusung; Henry A Erlich; Elizabeth A Trachtenberg; Stephan R Targan; Dermot P B McGovern; James R Heath; Jonathan Braun
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

7.  Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.

Authors:  Karen A O'Connell; Yefei Han; Thomas M Williams; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Comparison of the rapidly evolving KIR locus in Parsis and natives of India.

Authors:  S Kulkarni; R M Single; M P Martin; R Rajalingam; R Badwe; N Joshi; M Carrington
Journal:  Immunogenetics       Date:  2008-03-20       Impact factor: 2.846

9.  KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.

Authors:  José A Campillo; Isabel Legaz; M Rocío López-Álvarez; José Miguel Bolarín; Beatriz Las Heras; Manuel Muro; Alfredo Minguela; María R Moya-Quiles; Rosa Blanco-García; Helios Martínez-Banaclocha; Ana M García-Alonso; M Rocío Alvarez-López; Jorge A Martínez-Escribano
Journal:  Immunogenetics       Date:  2013-01-31       Impact factor: 2.846

10.  KIR gene content diversity in four Iranian populations.

Authors:  Elham Ashouri; Shirin Farjadian; Elaine F Reed; Abbas Ghaderi; Raja Rajalingam
Journal:  Immunogenetics       Date:  2009-06-12       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.